TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for ANXA1
check button Gene summary
Basic gene informationGene symbolANXA1
Gene nameannexin A1
SynonymsANX1|LPC1
CytomapUCSC genome browser: 9q21.13
Type of geneprotein-coding
RefGenesNM_000700.2,
Descriptionannexin I (lipocortin I)annexin-1calpactin IIcalpactin-2chromobindin-9phospholipase A2 inhibitory protein
Modification date20141222
dbXrefs MIM : 151690
HGNC : HGNC
Ensembl : ENSG00000135046
HPRD : 01060
Vega : OTTHUMG00000020016
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ANXA1
BioGPS: 301
PathwayNCI Pathway Interaction Database: ANXA1
KEGG: ANXA1
REACTOME: ANXA1
Pathway Commons: ANXA1
ContextiHOP: ANXA1
ligand binding site mutation search in PubMed: ANXA1
UCL Cancer Institute: ANXA1
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesHPA,GTExHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Esophagus
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)ESCA
Reference showing the relevant tissue of ANXA1
Description by TissGene annotationsCancer gene
TissgsLTS
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0018149peptide cross-linking10908733
GO:0030216keratinocyte differentiation10908733
GO:0031340positive regulation of vesicle fusion2138016
GO:0071385cellular response to glucocorticoid stimulus2936963
GO:0018149peptide cross-linking10908733
GO:0030216keratinocyte differentiation10908733
GO:0031340positive regulation of vesicle fusion2138016
GO:0071385cellular response to glucocorticoid stimulus2936963


Top
TissGeneExp for ANXA1

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
THCA3.0279822881.4223094071.6056728817.29E-136.73E-12
PRAD-0.169089420.853020196-1.0221096154.36E-084.55E-07
KIRP0.842897119-1.0593997561.9022968752.40E-092.09E-08
HNSC3.4814023515.260993049-1.7795906982.04E-061.43E-05
KIRC0.519538785-0.8900681591.4096069441.73E-191.31E-18
BRCA-0.1817059522.355751066-2.5374570189.45E-531.12E-50


Top
TissGene-miRNA for ANXA1

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for ANXA1
TissGeneSNV for ANXA1

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.S27LBRCA1
p.R188QSTAD1
p.R124CSKCM1
p.M1IUCEC1
p.P32ABLCA1
p.R72QACC1
p.E148*BLCA1
p.V301ICOAD1
p.R303HKIRC1
p.R212KSKCM1
p.S173PBLCA1
p.K294RCOAD1
p.M308TSTAD1
p.R298KSKCM1
p.D135VPAAD1
p.R234CUCEC1
p.A179TCOAD1
p.A313TBLCA1
p.A35VSARC1
p.S170*LUAD1
p.D167YREAD1
p.F221LPRAD1
p.E280*LUSC1
p.E122*HNSC1
p.R144IREAD1
p.F277LCOAD1
p.T64ASKCM1
p.E17KSKCM1
p.R72QUCEC1
p.R303CLGG1
p.R124HUCEC1
p.P40LSKCM1
p.G33RCOAD1
p.P44LSKCM1
p.L104PPAAD1
p.P44SBLCA1
p.F118YSARC1
p.T132AHNSC1
p.R188QREAD1
p.R303CKICH1
p.V268MSTAD1
p.M308ISKCM1
p.V220MUCEC1
p.V108ALIHC1
p.E280DSTAD1
p.I267VSTAD1
p.I138SPAAD1
p.E148KSKCM1
p.Q23XLGG1


Top
TissGeneCNV for ANXA1

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for ANXA1

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0ChiTaRsNACF126160ANXA1-ARPC3chr9:75775232chr12:110873951
Chimerdb3.0ChiTaRsNACB132862ANXA1-U2SURPchr9:75775236chr3:142769845
Chimerdb3.0ChiTaRsNABF805488H2AFY2-ANXA1chr10:71855431chr9:75775753
Chimerdb3.0ChiTaRsNABF873709ANXA1-MIR548AE2chr9:75770143chr16:48400529


Top
TissGeneNet for ANXA1

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
ANXA1, SQSTM1, SIRT7, HMGA1, UBC, YWHAZ, SRC, RIPK1, GAPDH, CD4, FPR1, UBE3A, RPA1, OTUB1, PRKCI, PLA2G4A, ANXA5, DLG3, C1orf123, S100A11, ATG4B (tumor)ANXA1, HMGA1, YWHAQ, UBE2D1, CD4, FPR1, MYL12A, EGFR, KRT8, UBE3A, UNC119, TGM2, FAF1, PLA2G4A, ANXA5, DLG3, C1orf123, S100A11, USP25, DYSF, CSAD (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
ANXA1, SIRT7, COPS6, CUL5, SUMO2, SRC, CCT7, RIPK1, FPR1, EGFR, KRT8, APBB1, KLHL23, PLA2G4A, ANXA5, DLG3, C1orf123, S100A11, DYSF, PPM1B, USPL1 (tumor)ANXA1, COPS6, UBC, SRC, CCT7, RIPK1, CD4, NFKBIA, FPR1, MYL12A, RPA1, TGM2, APBB1, KLHL23, PLA2G4A, ANXA5, S100A11, DYSF, CSAD, ATG4B, USPL1 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
ANXA1, SQSTM1, SIRT7, HMGA1, YWHAZ, SUMO2, KIAA0101, SRC, RIPK1, YWHAQ, UBE2I, UCHL5, TGM2, OTUB1, APBB1, KLHL23, XRCC6, ANXA5, C1orf123, S100A11, PPM1B (tumor)ANXA1, SQSTM1, SIRT7, UBC, YWHAZ, RIPK1, YWHAQ, CD4, MGMT, KRT8, UCHL5, UNC119, TGM2, OTUB1, APBB1, FAF1, KLHL23, PLA2G4A, S100A11, DYSF, USPL1 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
ANXA1, SQSTM1, SIRT7, HMGA1, YWHAZ, IKBKG, RELA, RIPK1, UBE2D1, CD4, UBE2I, NFKBIA, FPR1, MYL12A, KRT8, UCHL5, TRPM7, TGM2, ANXA5, DLG3, USP25 (tumor)ANXA1, SQSTM1, HMGA1, RELA, SRC, RIPK1, YWHAQ, SUMO1, CD4, NFKBIA, FPR1, MYL12A, MGMT, KRT8, TRPM7, UBE3A, UNC119, TGM2, DLG3, C1orf123, S100A11 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
ANXA1, SQSTM1, YWHAZ, KIAA0101, RIPK1, YWHAQ, UBE2D1, CD4, UBE2I, NFKBIA, FPR1, MYL12A, KRT8, UCHL5, TRPM7, UNC119, TGM2, OTUB1, FAF1, ANXA5, DLG3 (tumor)ANXA1, CUL5, UBC, YWHAZ, SUMO2, RIPK1, YWHAQ, UBE2D1, SUMO1, GAPDH, CD4, UBE2I, FPR1, MYL12A, TRPM7, TGM2, APBB1, ANXA5, DLG3, C1orf123, S100A11 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
ANXA1, CUL5, HMGA1, UBC, YWHAZ, KIAA0101, RIPK1, YWHAQ, UBE2D1, CD4, UBE2I, FPR1, MYL12A, KRT8, UCHL5, TRPM7, RPA1, TGM2, ANXA5, S100A11, DYSF (tumor)ANXA1, SQSTM1, COPS6, CUL5, YWHAZ, YWHAQ, UBE2I, MYL12A, MGMT, KRT8, TRPM7, TGM2, APBB1, PRKCI, FAF1, ANXA5, DLG3, S100A11, USP25, DYSF, PPM1B (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
ANXA1, COPS6, HMGA1, YWHAZ, SUMO2, SRC, RIPK1, UBE2D1, SUMO1, UBE2I, NFKBIA, FPR1, MYL12A, MGMT, KRT8, APBB1, PRKCI, PLA2G4A, ANXA5, DLG3, S100A11 (tumor)ANXA1, SIRT7, COPS6, YWHAZ, UBE2D1, SUMO1, CD4, FPR1, MYL12A, MGMT, C14orf1, TGM2, APBB1, PLA2G4A, ANXA5, DLG3, S100A11, USP25, DYSF, ATG4B, USPL1 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
ANXA1, HMGA1, UBC, YWHAZ, RELA, SRC, RIPK1, YWHAQ, UBE2D1, NFKBIA, FPR1, MYL12A, KRT8, UCHL5, RPA1, FAF1, PLA2G4A, XRCC6, ANXA5, DLG3, S100A11 (tumor)ANXA1, UBC, SUMO2, UBE2D1, CD4, FPR1, MYL12A, EGFR, C14orf1, UNC119, TGM2, KLHL23, PLA2G4A, ANXA5, DLG3, C1orf123, S100A11, USP25, DYSF, PPM1B, ATG4B (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
ANXA1, HMGA1, UBC, YWHAZ, RELA, RIPK1, YWHAQ, UBE2D1, SUMO1, NFKBIA, FPR1, MYL12A, EGFR, KRT8, RPA1, OTUB1, FAF1, XRCC6, ANXA5, DLG3, S100A11 (tumor)ANXA1, SIRT7, HMGA1, UBC, YWHAZ, YWHAQ, GAPDH, NFKBIA, MYL12A, MGMT, EGFR, C14orf1, APBB1, PRKCI, FAF1, KLHL23, S100A11, USP25, CSAD, ATG4B, USPL1 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
ANXA1, SQSTM1, COPS6, CUL5, YWHAZ, SUMO2, RELA, SRC, RIPK1, GAPDH, CD4, UBE2I, FPR1, EGFR, KRT8, TRPM7, PRKCI, KLHL23, XRCC6, ATG4B, USPL1 (tumor)ANXA1, SQSTM1, SIRT7, HMGA1, KIAA0101, CCT7, RIPK1, GAPDH, CD4, NFKBIA, FPR1, MYL12A, EGFR, TGM2, APBB1, FAF1, PLA2G4A, ANXA5, S100A11, USP25, DYSF (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
ANXA1, SQSTM1, CUL5, UBC, YWHAZ, SRC, YWHAQ, UBE2D1, CD4, FPR1, MGMT, EGFR, KRT8, UCHL5, C14orf1, PRKCI, FAF1, ANXA5, S100A11, USP25, CSAD (tumor)ANXA1, UBC, YWHAZ, RELA, SRC, UBE2D1, NFKBIA, FPR1, MYL12A, MGMT, EGFR, UCHL5, UNC119, KLHL23, PLA2G4A, ANXA5, C1orf123, S100A11, USP25, PPM1B, ATG4B (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
ANXA1, SQSTM1, HMGA1, UBC, YWHAZ, KIAA0101, RELA, YWHAQ, UBE2D1, NFKBIA, FPR1, MYL12A, KRT8, RPA1, PRKCI, ANXA5, S100A11, USP25, DYSF, PPM1B, CSAD (tumor)ANXA1, HMGA1, YWHAZ, SUMO2, RELA, SRC, YWHAQ, UBE2D1, UBE2I, FPR1, MYL12A, EGFR, UCHL5, UNC119, TGM2, FAF1, PLA2G4A, XRCC6, ANXA5, S100A11, USP25 (normal)
bullet pointbullet point


Top
TissGeneProg for ANXA1

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for ANXA1
TissGeneDrug for ANXA1

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB00288AmcinonideAgonistSmall moleculeApproved
DB01234DexamethasoneAgonistSmall moleculeApproved|Investigational|Vet_approved
DB00741HydrocortisoneAgonistSmall moleculeApproved|Vet_approved


Top
TissGeneDisease for ANXA1

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0596263Carcinogenesis15BeFree
umls:C0006142Malignant neoplasm of breast14BeFree
umls:C0678222Breast Carcinoma12BeFree
umls:C0027627Neoplasm Metastasis11BeFree,CTD_human,RGD
umls:C0007137Squamous cell carcinoma9BeFree,CTD_human,LHGDN
umls:C0376358Malignant neoplasm of prostate8BeFree
umls:C0600139Prostate carcinoma8BeFree
umls:C0178874Tumor Progression7BeFree
umls:C0242379Malignant neoplasm of lung4BeFree
umls:C0524851Neurodegenerative Disorders4BeFree
umls:C0684249Carcinoma of lung4BeFree
umls:C2239176Liver carcinoma4BeFree
umls:C0001418Adenocarcinoma3BeFree,LHGDN
umls:C0004114Astrocytoma3BeFree
umls:C0005684Malignant neoplasm of urinary bladder3BeFree
umls:C0007133Carcinoma, Papillary3BeFree
umls:C0021368Inflammation3LHGDN,RGD
umls:C0024623Malignant neoplasm of stomach3BeFree
umls:C0024667Animal Mammary Neoplasms3CTD_human
umls:C0033578Prostatic Neoplasms3CTD_human,LHGDN
umls:C0042164Uveitis3BeFree,RGD
umls:C0152013Adenocarcinoma of lung (disorder)3BeFree,CTD_human
umls:C0278996Cancer of Head and Neck3BeFree
umls:C0279626Squamous cell carcinoma of esophagus3BeFree,CTD_human
umls:C0699791Stomach Carcinoma3BeFree
umls:C0699885Carcinoma of bladder3BeFree
umls:C1458155Mammary Neoplasms3BeFree,LHGDN
umls:C0002395Alzheimer's Disease2BeFree
umls:C0004364Autoimmune Diseases2BeFree
umls:C0009324Ulcerative Colitis2BeFree
umls:C0009402Colorectal Carcinoma2BeFree
umls:C0010346Crohn Disease2BeFree
umls:C0011854Diabetes Mellitus, Insulin-Dependent2BeFree
umls:C0011860Diabetes Mellitus, Non-Insulin-Dependent2BeFree,GAD
umls:C0014175Endometriosis2BeFree,LHGDN
umls:C0014474Ependymoma2BeFree
umls:C0016667Fragile X Syndrome2BeFree
umls:C0017638Glioma2BeFree
umls:C0019693HIV Infections2BeFree
umls:C0020429Hyperalgesia2RGD
umls:C0020538Hypertensive disease2CTD_human,RGD
umls:C0022116Ischemia2BeFree,RGD
umls:C0024121Lung Neoplasms2BeFree,LHGDN
umls:C0024141Lupus Erythematosus, Systemic2BeFree
umls:C0024198Lyme Disease2BeFree
umls:C0024232Lymphatic Metastasis2BeFree,CTD_human
umls:C0024668Mammary Neoplasms, Experimental2CTD_human,RGD
umls:C0027430Nasal Polyps2BeFree
umls:C0032002Pituitary Diseases2BeFree
umls:C0038454Cerebrovascular accident2BeFree
umls:C0235974Pancreatic carcinoma2BeFree
umls:C0280324Laryngeal Squamous Cell Carcinoma2BeFree
umls:C0282612Prostatic Intraepithelial Neoplasias2LHGDN
umls:C0546837Malignant neoplasm of esophagus2BeFree
umls:C1168327High-Grade Prostatic Intraepithelial Neoplasia2BeFree
umls:C1527249Colorectal Cancer2BeFree
umls:C1709246Non-Neoplastic Disorder2BeFree
umls:C0003873Rheumatoid Arthritis1LHGDN
umls:C0004096Asthma1BeFree
umls:C0005683Urinary Bladder Calculi (disorder)1BeFree
umls:C0005695Bladder Neoplasm1LHGDN
umls:C0006111Brain Diseases1BeFree
umls:C0007107Malignant neoplasm of larynx1BeFree
umls:C0007112Adenocarcinoma of prostate1BeFree
umls:C0007113Rectal Carcinoma1BeFree
umls:C0007115Malignant neoplasm of thyroid1BeFree
umls:C0007134Renal Cell Carcinoma1RGD
umls:C0007138Carcinoma, Transitional Cell1BeFree,LHGDN,RGD
umls:C0007222Cardiovascular Diseases1BeFree
umls:C0007282Carotid Stenosis1BeFree
umls:C0007785Cerebral Infarction1RGD
umls:C0007786Brain Ischemia1RGD
umls:C0007847Malignant tumor of cervix1BeFree
umls:C0009319Colitis1RGD
umls:C0010674Cystic Fibrosis1BeFree
umls:C0011853Diabetes Mellitus, Experimental1RGD
umls:C0014072Experimental Autoimmune Encephalomyelitis1RGD
umls:C0014859Esophageal Neoplasms1BeFree,LHGDN
umls:C0017636Glioblastoma1BeFree
umls:C0019163Hepatitis B1BeFree
umls:C0019196Hepatitis C1BeFree
umls:C0020550Hyperthyroidism1RGD
umls:C0020676Hypothyroidism1RGD
umls:C0021390Inflammatory Bowel Diseases1BeFree
umls:C0021831Intestinal Diseases1BeFree
umls:C0021841Intestinal Neoplasms1BeFree
umls:C0022658Kidney Diseases1CTD_human
umls:C0023055Laryngeal neoplasm1LHGDN
umls:C0023418leukemia1BeFree
umls:C0023443Hairy Cell Leukemia1BeFree
umls:C0023467Leukemia, Myelocytic, Acute1BeFree
umls:C0023893Liver Cirrhosis, Experimental1RGD
umls:C0023895Liver diseases1LHGDN
umls:C0023903Liver neoplasms1BeFree
umls:C0024115Lung diseases1BeFree
umls:C0024299Lymphoma1BeFree
umls:C0024530Malaria1BeFree
umls:C0025202melanoma1BeFree
umls:C0026640Mouth Neoplasms1CTD_human
umls:C0026847Spinal Muscular Atrophy1BeFree
umls:C0026850Muscular Dystrophy1BeFree,LHGDN
umls:C0027055Myocardial Reperfusion Injury1RGD
umls:C0027626Neoplasm Invasiveness1CTD_human
umls:C0027765nervous system disorder1BeFree
umls:C0027814Neuritis, Autoimmune, Experimental1RGD
umls:C0027819Neuroblastoma1BeFree
umls:C0028945oligodendroglioma1BeFree
umls:C0029463Osteosarcoma1BeFree
umls:C0030524Paratuberculosis1BeFree
umls:C0032231Pleurisy1RGD
umls:C0034069Pulmonary Fibrosis1RGD
umls:C0036341Schizophrenia1BeFree
umls:C0036916Sexually Transmitted Diseases1BeFree
umls:C0038354Stomach Diseases1CTD_human
umls:C0038356Stomach Neoplasms1RGD
umls:C0040136Thyroid Neoplasm1LHGDN
umls:C0041296Tuberculosis1BeFree
umls:C0041341Tuberous Sclerosis1BeFree
umls:C0079731B-Cell Lymphomas1BeFree
umls:C0086543Cataract1RGD
umls:C0149925Small cell carcinoma of lung1BeFree
umls:C0151546Oral Cavity Carcinoma1BeFree
umls:C0152018Esophageal carcinoma1BeFree
umls:C0153381Malignant neoplasm of mouth1BeFree
umls:C0153601Malignant neoplasm of penis1BeFree
umls:C0206663Neuroectodermal Tumor, Primitive1BeFree
umls:C0220756Niemann-Pick Disease, Type C1BeFree
umls:C0233794Memory impairment1BeFree
umls:C0235031Neurologic Symptoms1BeFree
umls:C0238348Squamous cell carcinoma of penis1BeFree
umls:C0238461Anaplastic thyroid carcinoma1BeFree
umls:C0267750Acute peritonitis1BeFree
umls:C0278827Bladder cancer recurrent1BeFree
umls:C0279628Adenocarcinoma Of Esophagus1BeFree
umls:C0302592Cervix carcinoma1BeFree
umls:C0333186Restenosis1BeFree
umls:C0338106Adenocarcinoma of colon1BeFree
umls:C0346153Breast Cancer, Familial1BeFree
umls:C0376634Craniofacial Abnormalities1CTD_human
umls:C0476073Papillary neoplasm1BeFree
umls:C0549473Thyroid carcinoma1BeFree
umls:C0585442Osteosarcoma of bone1BeFree
umls:C0595989Carcinoma of larynx1BeFree
umls:C0700095Central neuroblastoma1BeFree
umls:C0740277Bile duct carcinoma1BeFree
umls:C0751396Well Differentiated Oligodendroglioma1BeFree
umls:C0853105Penis carcinoma1BeFree
umls:C0993582Arthritis, Experimental1RGD
umls:C1257930Mammary Carcinoma, Human1BeFree
umls:C1271104Blood pressure finding1GAD
umls:C1272641Systemic arterial pressure1GAD
umls:C1290884Inflammatory disorder1BeFree
umls:C1335110Oligodendroglial Neoplasm1BeFree
umls:C1561535Creatinine finding1GAD
umls:C1561549Glomerular filtration rate finding1GAD
umls:C1621958Glioblastoma Multiforme1BeFree
umls:C1704272Benign Prostatic Hyperplasia1BeFree
umls:C1800706Idiopathic Pulmonary Fibrosis1BeFree,LHGDN
umls:C1848199X-Linked Lissencephaly1BeFree
umls:C2609414Acute kidney injury1RGD
umls:C2931822Nasopharyngeal carcinoma1BeFree
umls:C2937358Cerebral Hemorrhage1RGD
umls:C3160917Bladder pain syndrome1BeFree
umls:C3665346Unspecified visual loss1BeFree